"I have spent four decades of my life thinking about how to treat patients with the Ebola virus. So this is what my life has achieved," Dr Jean-Jacques Mu Members, with his team Researchers, have discovered a new Ebola treatment that can cure symptoms in just one hour told BBC .
Four drugs have recently been trialled in patients in the Democratic Republic of the Congo, where Ebola killed nearly 1,900 people last year. .
On Tuesday, two people cured Ebola using experimental drugs were released from a treatment center in Rubber, DR Congo, and reunited with their families.
According to the World Health Organization
(WHO), two other treatments, called ZMapp and Remdesivir, are
used during the massive Ebola epidemic in Sierra Leone, Liberia and Guinea,
fell from trials because new experimental drugs were in the majority
The DRC trial, which began in November, has been halted as all Ebola treatment units have been asked to use two experimental or monoclonal antibody drugs.
"From now on, we will never say that Ebola will not cure," said Dr Mu Members, who is also the general director of the National Institute for Biomedical Research of the Congo , overseeing the trial. "These advancements will help save thousands of lives."
In the DRC, where there is a major outbreak of the virus – the second largest ever – the biggest challenge to control the virus includes frequent attacks by rebels and high mobility of the population . At present, suspicions by authorities and health agencies are factors that impede efforts to contain the response, experts say.
Member, recently joined by scientists to announce
the test results, he said, news of a cure could change its course
"Now we can say that 90 percent can go out of treatment, they'll start believing it and build trust," said the 77-year-old, who was part of the team that discovered Ebola 43 years ago. "The first ones to send this information were the patients themselves."
Dr. Mu Members, referred to as a "true hero," was
fighting Ebola since it first appeared in the DRC (then Zaire) in 1976.
At the age of 34, Mu Members was the first virologist to detect an Ebola
patient and he helped fight all nine of the outbreaks to strike
his country ever since.
He initiated the use of survivors' blood serum – which contained antibodies – to save patients. Two treatment experiments that have proven successful have been dropped from his original research, according to The New York Times .
Asked how he felt about it, he said: "I was
small sentimental. This idea has been around for a long time, and I have waited patiently
para rito. I'm happy, and I can't believe it. ”
According to BBC the new drugs, named REGN-EB3 and mAb114, work by attacking the Ebola virus with antibodies, neutralizing its effect on cells of man.
developed using antibodies harvested from Ebola survivors while REGN-EB3
derived from antibodies generated within mice infected with the disease, "the
Dr Anthony Fauci, director
of the NIAID says: "They are the" first drugs, in a scientific sense
study, clearly showed a significant reduction in mortality. ”
Of patients given
the two experimental drugs in the study, 29% in REGN-EB3 and 34% in mAb114
died. In contrast, 49% in ZMapp and 53% in Remdesivir (the two previously
the treatment) has died, according to the NIAID.
The agency added that
survival rate in patients with low levels of virus in their blood
was as high as 94% when they were given REGN-EB3, and 89% when in mAb114.
In effect, the
The findings mean that more than 90% of people can survive if they are treated
early on, according to the team of scientists who worked on the test.
The team is also hoping that the deadly Ebola virus can become an easily preventable and curable disease.  Why Ebola is dangerous
The Ebola virus (EVD) is a very serious, often fatal disease in humans. It is often transmitted from animals to humans, and then from humans to humans by direct contact with infected blood, body fluids or organs, or indirectly by contact in contaminated areas.
Formerly known as Ebola haemorrhagic fever, the disease was named after the Ebola River in the DRC. It was first discovered in 1976.
According to the WHO, the incubation period is between two and 21 days. Some of the first symptoms include fever fatigue, muscle aches, headaches and sore throat. Other symptoms are vomiting, diarrhea, rash, symptoms of kidney and liver function, and in some cases, both internal and external bleeding.
Humans remain infectious until their blood contains the virus and can also persist in various fluids including amniotic and placenta fluid in pregnant women and breast milk in women who breastfeed time of infection.